The confused oncologic patient: a rational clinical approach.
The purpose of this review is to provide a practical clinical approach to confusion in the patient with cancer. Confusion in the cancer population has a broader differential diagnosis than in the general medical population. The clinician must consider the usual differential diagnoses as well as causes unique to the cancer patient including direct complications from the cancer and indirect complications related to cancer treatment.



In the recent age of precision medicine, the oncologist now utilizes the genomic profile of both the patient and the tumor to provide advanced biologic therapies including targeted anticancer drugs, antiangiogenic agents, and immunotherapy. Such advances carry with them an emerging pattern of neurotoxicity which, although less well described in the literature, is now an important consideration to the clinical approach to confusion in cancer patients.



Confusion is the most common neurologic complication in cancer and is associated with significant morbidity, mortality, and prolonged hospital stays resulting in increased healthcare costs. Early recognition and treatment of delirium is essential to improve clinical outcomes.
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Craig
C
Nolan
Lisa M
LM
DeAngelis
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003221:Confusion / Q000175:diagnosis / Q000209:etiology*; D003693:Delirium / Q000175:diagnosis / Q000209:etiology*; D003937:Diagnosis, Differential; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy
D000970:Antineoplastic Agents
Palliat Support Care. 2015 Aug;13(4):859-64
24967513
Neuro Oncol. 2014 Jun;16(6):771-8
24637228
Clin Infect Dis. 2005 Mar 1;40(5):738-44
15714422
Crit Care. 2014 May 23;18(3):R106
24886875
Eur J Pharmacol. 2016 Apr 15;777:78-87
26939882
Cancer Immunol Res. 2015 Jun;3(6):598-601
25922203
Cancer. 2014 Aug 15;120(16):2464-71
24771533
Biol Blood Marrow Transplant. 2015 Jun;21(6):1091-8
25708217
Blood Rev. 2015 Mar;29(2):93-100
25445718
Cancer Immunol Res. 2015 May;3(5):464-9
25649350
Leuk Lymphoma. 2013 Apr;54(4):894-6
23039261
Nat Rev Clin Oncol. 2015 Feb;12(2):77-92
25178632
J Clin Oncol. 2013 Jul 10;31(20):e360-3
23733774
Sci Transl Med. 2014 Feb 19;6(224):224ra25
24553386
Palliat Support Care. 2015 Aug;13(4):1087-92
25191904
World J Oncol. 2016 Feb;7(1):5-12
26998187
Ann Hematol. 2016 Mar;95(4):563-73
26758269
J Clin Endocrinol Metab. 2014 Nov;99(11):4078-85
25078147
Cancer Res. 2014 Jun 1;74(11):2913-21
24840647
Oncogenesis. 2016 Feb 22;5:e200
26900952
Ann Indian Acad Neurol. 2013 Jul;16(3):418-21
24101834
J Clin Oncol. 2012 Feb 20;30(6):e76-8
22203769
Semin Intervent Radiol. 2015 Mar;32(1):3-9
25762840
JAMA Neurol. 2015 Oct;72(10):1163-9
26280228
Endocr Relat Cancer. 2014 Mar 07;21(2):371-81
24610577
Jpn J Clin Oncol. 2015 Oct;45(10):934-40
26185141
Support Care Cancer. 2016 May;24(5):2155-2162
26559193
J Oncol Pharm Pract. 2017 Jul;23 (5):344-349
27208016
Oncologist. 2011;16(2):136-45
21285392
Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):429-51
25837905
Nat Rev Clin Oncol. 2016 Feb;13(2):92-105
26391778
Anticancer Res. 2015 Dec;35(12):6761-3
26637893
J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1362-8
25589780
N Engl J Med. 2013 Jul 11;369(2):197-8
23841743
Blood. 2009 May 14;113(20):4834-40
19264918
J Clin Oncol. 2014 Aug 20;32(24):2617-26
25071135
Sci Transl Med. 2015 Sep 2;7(303):303ra139
26333935
Arch Neurol. 2000 Dec;57(12):1727-31
11115238
Oncologist. 2015 Dec;20(12 ):1425-31
26417036
Cancer Discov. 2016 Jun;6(6):664-79
27076371
J Oncol Pharm Pract. 2017 Jan;23 (1):71-74
26655111
N Engl J Med. 2011 May 12;364(19):1844-54
21561350
Cancer Epidemiol. 2015 Dec;39(6):901-7
26520619
N Am J Med Sci. 2015 Nov;7(11):483-93
26713296
J Neurooncol. 2012 Jul;108(3):527-34
22467138
Cancer J. 2015 Nov-Dec;21(6):470-4
26588678
J Oncol Pharm Pract. 2016 Dec;22(6):806-810
26467267
JAMA. 1996 Mar 20;275(11):852-7
8596223
Blood. 2015 Jun 25;125(26):4017-23
25999455
Invest New Drugs. 2015 Jun;33(3):751-4
25467090
Support Care Cancer. 2015 Aug;23(8):2427-33
25617070
Blood. 2016 Mar 17;127(11):1410-6
26755709
J Gerontol A Biol Sci Med Sci. 2015 Oct;70(10 ):1289-95
26215633
Psychosomatics. 2016 Jan-Feb;57(1):71-81
26791514
J Clin Oncol. 2016 Mar 20;34(9):987-1011
26846975
Rev Bras Psiquiatr. 2015 Jul-Sep;37(3):197-202
26376051
Cancer Biol Med. 2015 Dec;12(4):261-74
26779363
Palliat Med. 2015 Oct;29(9):826-33
25881622
BMC Res Notes. 2015 Jul 26;8:316
26209970
J Prev Alzheimers Dis. 2016 Mar;3(1):53-64
26900574
World J Crit Care Med. 2015 May 04;4(2):130-8
25938028
Blood. 2015 Jun 25;125(26):4010-6
25999456
Handb Clin Neurol. 2014;121:1199-218
24365412
Radiat Oncol. 2013 Aug 21;8:204
23965287
J Pediatr Hematol Oncol. 2016 Aug;38(6):489-90
26907647
Korean J Gastroenterol. 2014 Sep 25;64(3):158-63
25252865
J Pain Symptom Manage. 2014 Aug;48(2):215-30
24879997
J Crit Care. 2015 Aug;30(4):799-807
25957498
World J Urol. 2016 Oct;34(10 ):1465-72
26914818
Curr Psychiatry Rep. 2015 Mar;17 (3):550
25663153
J Clin Oncol. 2015 Oct 20;33(30):3475-84
26282648
Mediators Inflamm. 2015;2015:801685
26504362
Lancet Neurol. 2016 Apr;15(4):391-404
26906964
Ther Clin Risk Manag. 2015 Dec 04;11:1779-88
26675713
Oncologist. 2015 Jul;20(7):806-11
26032137
J Alzheimers Dis. 2016 Feb 27;52(1):33-42
26967207
J Neurooncol. 2016 May;128(1):75-84
26900076
J Natl Compr Canc Netw. 2014 Dec;12 (12 ):1660-4; quiz 1664
25505206
J Oncol Pract. 2016 May;12(5):426-32
27170690
Biol Blood Marrow Transplant. 2016 Aug;22(8):1424-1430
27154848